Just a moment, the page is loading...
Browse ALL STUDIES
Keyword Search
View All Selected
Clear All
Login / Create Account
Login
Create Account
Home
About Us
Privacy Policy
Minimum System Requirements
How To Join
Mission
Data Sponsors
Researchers
How It Works
How to Request Data
Review of Requests
Data Sharing Agreement
Access to Data
Independent Review Panel
Metrics
FAQs
News
Help/Contact Us
Artificial Intelligence Algorithms for Analysis of Geographic Atrophy
Proposal
11915
Title of Proposed Research
Artificial Intelligence Algorithms for Analysis of Geographic Atrophy
Lead Researcher
Amitha Domalpally
Affiliation
Dept of Ophthalmology and Visual Sciences, University of Wisconsin, Madison.
Funding Source
Potential Conflicts of Interest
Data Sharing Agreement Date
29 April 2022
Lay Summary
Age-related macular degeneration (AMD) is a leading cause of vision loss in population over 50 years age in the United States. The advanced stage of AMD can be wet (also known as neovascular AMD) or dry (also known as geographic atrophy, GA). There are currently approved treatments for wet AMD but no known treatments for GA. The natural history of GA, which presents as atrophic patches in the retina, has been well studied in many clinical trials. However, it is still unclear what initiates the development of GA and why some lesions grow faster than others. The BAM study has a unique dataset of images obtained for the clinical trial including retinal photographs and specialized imaging called autofluorescence and OCT scans. The autofluorescence imaging and OCT scans provide insights into the retina beyond what the ophthalmologist can see and provide a means to fill the knowledge gap. Understanding development and growth of GA is key to developing targeted treatments. The purpose of this study is to use artificial intelligence (AI) algorithms to identify additional risk factors beyond human perception in the natural history of geographic atrophy. AI has to date mostly been used for automated segmentation of GA. We aim to take this further by developing AI models for identifying risk factors and morphological features for future GA development, predict rapid progressors, and possible relationship to visual function.
Study Data Provided
[{ "PostingID": 19810, "Title": "GSK-BAM114341", "Description": "A phase 2, multi-centre, randomised, double-masked, placebo-controlled, parallel-group study to investigate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of GSK933776 in adult patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)" }]
Statistical Analysis Plan
We will utilize standard AI model validation metrics such as sensitivity, specificity, accuracy and F1 score. Dice coefficients will be utilized for lesion segmentation assessments and comparison with human grading or other imaging modalities. We propose, in addition, to utilize attention mechanism layers within our AI classifiers, and training our models to predict GA development. In doing this, we propose to use the attention maps to gain insight into the features the AI models use to classify images with the goal of identifying new features or feature modalities that can be used to predict GA progression.
Publication Citation
Amitha Domalpally, Robert Slater, Rachel E. Linderman, Rohit Balaji, Jacob Bogost, Rick Voland, Jeong Pak, Barbara A. Blodi, Roomasa Channa, Donald Fong, Emily Y. Chew. Strong versus Weak Data Labeling for Artificial Intelligence Algorithms in the Measurement of Geographic Atrophy, Ophthalmology Science, Volume 4, Issue 5,
2024
DOI:
https://doi.org/10.1016/j.xops.2024.100477.
© 2024 ideaPoint. All Rights Reserved.
Powered by ideaPoint.
Help
Privacy Policy
Cookie Policy
Help and Resources